Aspire Biopharma Holdings Inc (ASBP) concluded trading on Wednesday at a closing price of $0.33, with 71.86 million shares of worth about $23.71 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -97.14% during that period and on July 09, 2025 the price saw a gain of about 4.12%. Currently the company’s common shares owned by public are about 48.90M shares, out of which, 39.39M shares are available for trading.
Stock saw a price change of 5.16% in past 5 days and over the past one month there was a price change of -14.32%. Year-to-date (YTD), ASBP shares are showing a performance of -97.00% which decreased to -97.17% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.22 but also hit the highest price of $15.80 during that period. The average intraday trading volume for Aspire Biopharma Holdings Inc shares is 13.79 million. The stock is currently trading 3.99% above its 20-day simple moving average (SMA20), while that difference is down -3.32% for SMA50 and it goes to -94.82% lower than SMA200.
Aspire Biopharma Holdings Inc (NASDAQ: ASBP) currently have 48.90M outstanding shares and institutions hold larger chunk of about 2.90% of that.
The stock has a current market capitalization of $16.15M and its 3Y-monthly beta is at 0.72. It has posted earnings per share of -$1.71 in the same period. It has Quick Ratio of 0.22. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ASBP, volatility over the week remained 26.76% while standing at 15.91% over the month.
Analysts are in expectations that Aspire Biopharma Holdings Inc (ASBP) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same.
